AI assistant
Sending…
MKS INC — Director's Dealing 2012
Mar 1, 2012
30723_dirs_2012-03-01_7bade1fa-79d8-469e-aa37-98d904344df9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MKS INSTRUMENTS INC (MKSI)
CIK: 0001049502
Period of Report: 2012-02-28
Reporting Person: STEWART WILLIAM D (VP/GM, Vacuum Products)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-28 | Common Stock | M | 1446.079 | — | Acquired | 1446.079 | Direct |
| 2012-02-28 | Common Stock | M | 1018 | — | Acquired | 2464.079 | Direct |
| 2012-02-28 | Common Stock | F | 767 | $30.63 | Disposed | 1697.079 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-02-28 | Restricted Stock Unit | $ | M | 1446.079 | Disposed | Common Stock (1446.079) | Direct | |
| 2012-02-28 | Restricted Stock Unit | $ | M | 1018 | Disposed | Common Stock (1018) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 0.552 | Indirect |
Footnotes
F1: Each restricted stock unit represents the contingent right to receive one share of common stock of MKS Instruments, Inc.
F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
F3: These RSUs are subject to the achievement of performance criteria determined in the first year of the grant and thereafter vests in equal annual installments over three years.
F4: The RSUs vest in equal annual installments over three years.
More from MKS INC
Regulatory Filings
2026
May 28
Share Issue/Capital Change
2026
May 11
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 6
Board/Management Information
2026
Apr 6
Annual Report
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 31
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 20
Director's Dealing
2026
Mar 3